日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Rational design of FVIII sialylated peptides to target Siglec-3 and Siglec-9 and improve peptide formulations for reverse vaccines.

合理设计 FVIII 唾液酸化肽以靶向 Siglec-3 和 Siglec-9,并改进反向疫苗的肽制剂

Nardini Eleonora, Keumatio Doungstop Brigitte-Carole, Gerpe-Amor Tania, de Haas Aram M, de Kok Mike, Peterse Evert, Kalay Hakan, Li Rui-Jún E, Chiodo Fabrizio, Silipo Alba, Voorberg Jan, van Kooyk Yvette

Vaccination with DC-SIGN-Targeting αGC Liposomes Leads to Tumor Control, Irrespective of Suboptimally Activated T-Cells

即使T细胞活化程度不足,使用靶向DC-SIGN的αGC脂质体进行疫苗接种也能控制肿瘤。

de Haas, Aram M; Stolk, Dorian A; Schetters, Sjoerd T T; Goossens-Kruijssen, Laura; Keuning, Eelco; Ambrosini, Martino; Boon, Louis; Kalay, Hakan; Storm, Gert; van der Vliet, Hans J; de Gruijl, Tanja D; van Kooyk, Yvette

Therapeutic Liposomal Vaccines for Dendritic Cell Activation or Tolerance

用于激活或诱导耐受性的治疗性脂质体疫苗

Nagy, Noémi Anna; de Haas, Aram M; Geijtenbeek, Teunis B H; van Ree, Ronald; Tas, Sander W; van Kooyk, Yvette; de Jong, Esther C